Try our Advanced Search for more refined results

Sidley-Led Cytomx Seeks $106M IPO To Fund Cancer Drugs

By Tom Zanki (September 28, 2015, 5:46 PM EDT) -- Venture capital-backed biotech Cytomx Therapeutics Inc. on Monday set terms for an initial public offering, advised by Sidley Austin LLP, that could raise $106 million to develop its cancer immunotherapy drugs, making it the latest life sciences company to advance through the IPO pipeline amid an otherwise cool market....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!